Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

NCT01743404 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.

NCT NCT01743404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01743404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
Lead sponsor
Institute for Atherosclerosis Research, Russia
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2007
Completion date
June 30, 2013
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid atherosclerosis